Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with copays capped at $50 per ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

New weight-loss drugs promise transformative benefits, but soaring demand and massive cost projections leave Ireland facing ...

If there's one word which has dominated the weight loss world, it's GLP-1s. According to the poll RAND, approximately one in 12 Americans are on some form of GLP-1 and one in five women between the ...

See all the celebrities who've talked about semaglutide and tirzepitide GLP-1 drugs including Ozempic, Mounjaro, Zepbound and ...

The Australian Therapeutic Goods Administration (TGA) has updated and aligned safety warnings for people using GLP-1 and dual GIP/GLP-1 receptor agonists. For those not in the know, these are ...

Usage of GLP-1 medications has increased over the past 18 months, with highest adoption among women and adults aged 50-64, ...

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

Northwell Health reports that "Ozempic face" describes the facial changes from rapid weight loss using Ozempic, highlighting ...

Ozempic and Wegovy will be offered at lower prices from now until the end of March, manufacturer Novo Nordisk said Nov. 17 The discount applies to the lowest doses of the medication and is available ...